EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma

Yan Gao iD, Camille Canty, Laura R Prakash, Emmanuel Coronel, Matthew H G Katz, Rebecca A Snyder, Sinchita Roy-Chowdhuri iD

Cancer Cytopathology · 2026-12 · 134 (12)

DOI: 10.1002/cncy.70165 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Cancer Cytopathology, online erschienen am 10.11.2026. Verfasst von Yan Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, High-Throughput Nucleotide Sequencing, Endoscopic Ultrasound-Guided Fine Needle Aspiration. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Current clinical practice guidelines recommend molecular profiling for patients with pancreatic ductal adenocarcinoma (PDAC). However, endoscopic ultrasound–guided small specimens are often insufficient for next‐generation sequencing (NGS). In this study, the impact of a standardized protocol designed to optimize tissue acquisition for NGS was evaluated.

Methods

Quality assurance data from patients with suspected PDAC who underwent endoscopic ultrasound–guided tissue acquisition for NGS was retrospectively analyzed. A standardized workflow incorporating rapid onsite evaluation using predefined adequacy criteria, dedicated tissue procurement for cell block preparation, multidisciplinary communication, and prospective monitoring of molecular outcomes were evaluated using a successful NGS result as the primary endpoint.

Results

Of the 61 patients with confirmed PDAC by cytology, 49 specimens (80.3%) were deemed adequate for NGS during rapid onsite evaluation. Forty‐one specimens with a median tumor fraction of 30% underwent NGS. Median DNA and RNA yields were 20.8 ng/µL and 19.7 ng/µL, respectively. DNA‐based NGS was successful in 39 cases (95.1%), whereas RNA‐based fusion analysis succeeded in 22 cases (53.7%). Median turnaround time from specimen receipt to NGS reporting was 10 business days.

Conclusions

A standardized molecular adequacy protocol achieved high DNA sequencing success but did not substantially improve overall specimen adequacy compared with prior institutional experience. Intrinsic biologic features of PDAC, including low tumor cellularity and abundant desmoplastic stroma and nonneoplastic elements remain the principal barriers to molecular profiling. Future efforts that focus on improving tumor enrichment and optimizing RNA preservation may expand precision oncology access to patients with PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsHigh-Throughput Nucleotide SequencingEndoscopic Ultrasound-Guided Fine Needle AspirationEndosonographyHumansFemaleMaleAgedRetrospective StudiesMiddle AgedAged, 80 and overSpecimen Handling

Stichwörter der Autor:innen

comprehensive genomic profilingmolecular adequacynext‐generation sequencingpancreatic ductal adenocarcinomaquality assurancerapid on‐site evaluationtissue acquisition

Autor:innen und Institutionen

  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Gastroenterology & Hepatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Yan Gao, Sinchita Roy-Chowdhuri

Zitieren

APA

Gao, Y., Canty, C., Prakash, L. R., Coronel, E., Katz, M. H. G., Snyder, R. A., & Roy-Chowdhuri, S. (2026). Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma. Cancer Cytopathology, 134(12). https://doi.org/10.1002/cncy.70165

Vancouver

Gao Y, Canty C, Prakash LR, Coronel E, Katz MHG, Snyder RA, et al. Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma. Cancer Cytopathology. 2026;134(12). doi:10.1002/cncy.70165

BibTeX
@article{Gao2026,
  author = {Gao, Yan and Canty, Camille and Prakash, Laura R and Coronel, Emmanuel and Katz, Matthew H G and Snyder, Rebecca A and Roy-Chowdhuri, Sinchita},
  title = {Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma},
  journal = {Cancer Cytopathology},
  year = {2026},
  volume = {134},
  number = {12},
  doi = {10.1002/cncy.70165}
}
Kostenlos starten →